## Abstract ## Background Vascular endothelial growth factor (VEGF) is known to play a major role in angiogenesis. A soluble form of Flt‐1, a VEGF receptor, is potentially useful as an antagonist of VEGF, and accumulating evidence suggests the applicability of sFlt‐1 in tumor suppression. In the p
Tumor growth inhibiting effect of JB-1 ascitic fluid—I: An in vivo investigation
✍ Scribed by P. Bichel
- Book ID
- 113145141
- Publisher
- Elsevier Science
- Year
- 1970
- Weight
- 429 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0014-2964
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Inhibition of tumor angiogenesis is a promising approach for cancer therapy and the Tie‐2/angiopoietin pathway appears to play an important role. In the present study, we have developed strategies to explore the therapeutic potential of blocking the Tie‐2/angiopoietin pat
The simultaneous administration of 3'-deoxyadenosine N1-oxide (3'-dANO) and the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) or 2'-deoxycoformycin (2'-dCF) to mice bearing Ehrlich ascites tumor cells resistant to 3'-dANO resulted in 80%-90% inhibition of tumor growth i